Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

AM Rx vs NovoCare Pharmacy

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

5.9

AM Rx

Best for patients with insurance seeking brand-name GLP-1 access (review regulatory warnings carefully)
★★★☆☆3

Starting at $25/mo

Compounded SemaglutideOzempicWegovyZepbound
Visit AM Rx
8.7

NovoCare Pharmacy

Best for branded Wegovy at the lowest manufacturer-direct self-pay price
★★★★4.4

Starting at $199/mo

WegovyBrandManufacturer DirectAll 50 States
Visit NovoCare Pharmacy

Side-by-Side Comparison

FeatureAM RxNovoCare Pharmacy
Overall Score5.9/108.7/10
Starting Price$25/mo$199/mo
Editorial Rating3 ★ /54.4 ★ /5
Features6 features5 features
States Available050
Compounded✓ Yes
Brand Name✓ Yes✓ Yes
FSA/HSA Accepted
FDA Warnings2 warningsNone

Pros & Cons

AM Rx

Pros

  • Insurance coordination for brand-name GLP-1s — as low as $25/mo
  • All four major brand-name GLP-1s available (Ozempic, Wegovy, Zepbound, Mounjaro)
  • HSA and FSA accepted
  • Video visits available (not just async) with providers averaging 10+ years experience
  • Compounded semaglutide from $151/mo quarterly

Cons

  • Active FTC/DOJ lawsuit for deceptive billing and subscription practices (ROSCA violations)
  • Two FDA warning letters (Sept 2025, Feb 2026) for misbranding compounded GLP-1 products
  • Novo Nordisk false advertising lawsuit (Aug 2025)
  • Parent entity Zealthy has BBB D- rating with 2,370+ complaints
  • Trustpilot 2.0/5 — 85% one-star reviews citing billing disputes and unreachable support
  • No visible LegitScript certification or PCAB accreditation
  • No named pharmacy partners — compounding source not disclosed
  • No FDA compounding disclaimer on the website
  • State availability not publicly disclosed
  • Founder Kyle Robertson previously ran Cerebral, which settled FTC charges for similar practices
  • Same corporate entity (FitRX LLC) as Zealthy and FitRx — shares regulatory history

NovoCare Pharmacy

Pros

  • First-party manufacturer pharmacy — the most authoritative branded Wegovy channel possible
  • $199/month intro pricing for Wegovy 0.25 mg and 0.5 mg starter doses (through 6/30/2026) is the lowest brand-name self-pay price for the FDA-approved Wegovy product
  • $349/month standard self-pay for full-dose Wegovy is well below the ~$1,300/month list price at retail pharmacies
  • Ships to all 50 states; no telehealth-platform middleman fees
  • Cold-chain logistics handled by Novo Nordisk directly — no risk of mishandling between manufacturer and patient
  • Insurance-billing path also available via the standard NovoCare savings program

Cons

  • Wegovy only — no semaglutide for type 2 diabetes (Ozempic), no compounded GLP-1, no tirzepatide
  • Requires an existing valid Wegovy prescription — NovoCare Pharmacy does not employ prescribing clinicians or operate a telehealth intake. You need a separate visit (PCP, endocrinologist, or another telehealth provider) to get the script first
  • $199 intro pricing is dose-restricted (0.25 mg / 0.5 mg only) and time-limited (through 6/30/2026) — most patients on the maintenance 1.7 / 2.4 mg dose pay $349/month
  • No clinical support included with the pharmacy fulfillment — your prescribing clinician handles titration and side-effect monitoring
  • Manufacturer-set pricing can change at any time

Our Verdict

Winner: NovoCare PharmacyScore: 8.7/10

NovoCare Pharmacy edges out AM Rx with a higher overall score of 8.7/10 and is particularly strong for branded Wegovy at the lowest manufacturer-direct self-pay price. AM Rx remains a solid alternative, especially if you're looking for patients with insurance seeking brand-name GLP-1 access (review regulatory warnings carefully).

Glossary references

Key terms in this article, linked to their canonical definitions.

Related comparisons

Continue exploring AM Rx and NovoCare Pharmacy head-to-heads in the same category.

Or see the full category ranking.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.